切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2019, Vol. 12 ›› Issue (03): 166 -170. doi: 10.3877/cma.j.issn.1674-6899.2019.03.009

所属专题: 文献资源库

论著 上一篇    下一篇

剑突下与肋间入路胸腔镜胸腺扩大切除术的临床体会
张淼 1, 武文斌 1, 杨敦鹏 1, 刘冬 1 , ( ), 张辉 1, 胡正群 1   
  1. 1. 221009 徐州市中心医院胸外科
  • 收稿日期:2019-01-29 出版日期:2019-06-30
  • 通信作者: 刘冬

A clinical analysis on subxiphoid and intercostal video-assisted thoracoscopic extended thymectomy

Miao Zhang 1, Wenbin Wu 1, Dunpeng Yang 1, Dong Liu 1 , ( ), Hui Zhang 1, Zhengqun Hu 1   

  1. 1. Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou 221009, China
  • Received:2019-01-29 Published:2019-06-30
  • Corresponding author: Dong Liu
  • About author:
    Corresponding author: Liu Dong, Email:
目的

探讨经剑突下入路与肋间入路胸腔镜(video-assisted thoracoscopic surgery, VATS)胸腺扩大切除术的特点。

方法

回顾性分析2015年1月至2018年12月徐州市中心医院胸外科VATS胸腺扩大切除术的病例资料113例,依据术式不同分为经肋间多孔VATS (multiple-port VATS,MVATS)组46例(肋间MVATS组)、剑突下MVATS组40例与剑突下单孔VATS (uniportal VATS,UVATS)组27例(剑突下UVATS组)。比较手术相关参数的差异。

结果

肋间入路组5例、剑突下入路组7例术前合并重症肌无力(myasthenia gravis, MG)。患者无中转开胸手术或死亡。剑突下UVATS组3例中转剑突下MVATS。肋间MVATS组与剑突下MVATS组、剑突下UVATS组比较,手术时间短[(64.0±15.1) min比(71.4±18.1) min比(87.4±18.7) min, P<0.05],胸腔引流时间短[(1.5±0.7) d比(2.3±1.1) d比(2.9±1.3) d, P< 0.05]、胸腔引流量少[(131.4±66.5) ml比(169.9±110.6) ml比(231.5±111.9) ml, P< 0.05]、术后住院时间短[(1.9±1.1) d比(3.1±2.0) d比(3.7±2.8) d, P< 0.05],而术后1 d视觉模拟评分高[(4.2±1.3)分比(3.7±1.1)分比(3.5±1.2)分,P< 0.05]。剑突下UVATS组2例术后出现MG危象。CT提示剑突下MVATS组1例、剑突下UVATS组5例术后前纵隔脂肪影残留。

结论

剑突下入路VATS胸腺扩大切除术是可行的,但与肋间入路MVATS比较无显著优势。

Objective

To explore the clinical characteristics of video-assisted thoracoscopic (VATS) extended thymectomy via subxiphoid and intercostal approaches.

Methods

Clinical data of consecutive VATS extended thymectomy performed between Jan. 2015 and Dec. 2018 in Department of Thoracic Surgery of Xuzhou Central Hospital was retrospectively analyzed. The patients were divided into intercostal multiple VATS (MVATS) group, subxiphoid MVATS group and subxiphoid uniportal VATS (UVATS) group. The operation-related parameters were compared respectively among the groups.

Results

There were 5 cases in the intercostal group and 7 cases in the subxiphoid groups suffered from myasthenia gravies (MG) before surgery. There was no short-term mortality, or conversion to thoracotomy. Three patients in subxiphoid UVATS group converted to subxiphoid MVATS. Besides, as compared with the subxiphoid MVATS and UVATS group, the patients of intercostal MVATS group revealed shorter operation time [(64.0±15.1) min vs (71.4±18.1) min vs (87.4±18.7) min, P< 0.05], shorter chest tube drainage [(1.5±0.7) d vs (2.3±1.1) d vs (2.9±1.3) d, P< 0.05], smaller drainage volume [(131.4±66.5) ml vs (169.9±110.6) ml vs (231.5±111.9) ml, P<0.05], shorter postoperative stay [(1.9±1.1) d vs (3.1±2.0) d vs (3.7±2.8) d, P< 0.05], but higher pain score on the first postoperative day [(4.2±1.3) vs (3.7±1.1) vs (3.5±1.2), P<0.05]. In addition, subxiphoid UVATS group reported two cases of MG crisis after surgery. Besides, incomplete resection of anterior mediastinal fat tissue was found in 1 case in the subxiphoid MVATS group and 5 cases in the UVATS group, as shown by computered tomography after surgery.

Conclusions

Subxiphoid VATS extended thymectomy is feasible, but it does not indicate significant advantages as compared with intercostal MVATS approach.

表1 三组胸腔镜胸腺扩大切除术患者的一般资料比较
表2 胸腔镜胸腺扩大切除术的临床参数比较
1
Tomulescu V, Sgarbura O, Stanescu C, et al. Ten-year results of thoracoscopic unilateral extended thymectomy performed in nonthymomatous myasthenia gravis [J]. Ann Surg,2011, 254(5):761-766.
2
Meyer DM, Herbert MA, Sobhani NC, et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches [J]. Ann Thorac Surg,2009, 87(2):385-391.
3
Shiomi K, Kitamura E, Ono M, et al. Feasible and promising modified trans-subxiphoid thoracoscopic extended thymectomy for patients with myasthenia gravis [J]. J Thorac Dis, 2018,10(3):1747-1752.
4
Suda T. Single-port thymectomy using a subxiphoid approach—surgical technique [J]. Ann Cardiothorac Surg, 2016,5(1):56-58.
5
Lu Q, Zhao J, Wang J, et al. Subxiphoid and subcostal arch "three ports" thoracoscopic extended thymectomy for myasthenia gravis [J]. J Thorac Dis, 2018,10(3):1711-1720.
6
罗清泉,黄佳,李函玥. 非小细胞肺癌生物学意义微创治疗的研究:附700例Da Vinci机器人辅助肺部手术分析[J/CD]. 中华腔镜外科杂志(电子版), 2017,10(5):270-271.
7
马永富,杨博,赵明,等. 机器人辅助全胸腺切除术初步报道[J/CD]. 中华腔镜外科杂志(电子版),2017,10(2):74-76.
8
陈秀,韩冰,郭巍,等. 机器人胸腺和胸腺瘤切除术[J/CD]. 中华腔镜外科杂志(电子版), 2011, 4(4): 284-286.
9
江贤亮,徐美清,马冬春,等. 胸腔镜手术治疗纵隔肿瘤137例临床分析 [J]. 中华解剖与临床杂志,2016, 21(2): 165-166.
10
Chiu CH, Chao YK, Liu YH. Subxiphoid approach for video-assisted thoracoscopic surgery: an update [J]. J Thorac Dis, 2018,10(14):1662-1665.
11
Ponseti JM, Gamez J, Vilallonga R, et al. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis [J]. Eur J Cardiothorac Surg, 2008, 34(5):1062-1067.
12
Masaoka A, Monden Y, Seike Y, et al. Reoperation after transcervical thymectomy for myasthenia gravis [J]. Neurology, 1982, 32(1):83-85.
13
方文涛,傅剑华,沈毅,等. 胸腺肿瘤的诊疗:基于中国胸腺肿瘤协作组多中心回顾性研究的共识 [J]. 中国肺癌杂志,2016, 19(7): 414-417.
14
Xue L, Wang L, Dong J, et al. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis [J]. Eur J Cardiothorac Surg,2017, 52(4):692-697.
15
Zou J, Su C, Lun X, et al. Preoperative anxiety in patients with myasthenia gravis and risk for myasthenic crisis after extended transsternal thymectomy: a consort study [J]. Medicine (Baltimore),2016, 95(10):2828-2828.
16
Ando T, Omasa M, Kondo T, et al. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis [J]. Eur J Cardiothorac Surg,2015,48(5):705-709.
17
Yu S, Lin J, Fu X, et al. Risk factors of myasthenic crisis after thymectomy in 178 generalized myasthenia gravis patients in a five-year follow-up study [J]. Int J Neurosci,2014,124(11):792-798.
18
Watanabe A, Watanabe T, Obama T, et al. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis [J]. J Thorac Cardiovasc Surg,2004,127(3):868-876.
19
Leuzzi G, Meacci E, Cusumano G, et al. Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis [J]. Eur J Cardiothorac Surg,2014,45(4):76-88.
[1] 王伟, 王坤, 孙涛, 茹玉航, 刘晓. 血清肝素结合蛋白、C-反应蛋白和降钙素原对肺癌电视胸腔镜术后肺部细菌感染的预测价值[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(04): 257-262.
[2] 韩焱楠, 李春磊, 李民华. 单孔胸腔镜手术治疗自发性气胸患者术后血气指标及生活质量的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 459-461.
[3] 尉腊革, 李毅, 张建辉, 刘彦军, 李东迂, 栾中华. 单孔胸腔镜肺癌根治术后不同胸腔引流液量时拔管的康复分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 478-480.
[4] 吴勇, 陈健, 李成洁, 陈爱鸾, 沈伯雄. 不同浓度瑞芬太尼对胸腔镜下肺癌根治术患者围手术期免疫功能及肺功能的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 508-510.
[5] 刘春宏, 尹利群, 刘夏曦, 王中清, 胡庆波, 杨晓云. 纳布啡超前镇痛对胸腔镜肺癌根治术患者术后认知功能及PMN、ADP的影响[J]. 中华肺部疾病杂志(电子版), 2021, 14(03): 355-357.
[6] 郭俊唐, 王彬, 申磊磊, 梁朝阳, 刘阳. 胸腔镜前纵隔肿物切除术两种入路方式的对比分析[J]. 中华腔镜外科杂志(电子版), 2021, 14(04): 221-225.
[7] 代佑果, 苏有橦, 王嘉鑫, 胡义波, 吕煜, 韩潇, 陈林波. 单孔加一孔全腹腔镜远端胃癌根治术治疗Ⅰ期胃窦癌[J]. 中华腔镜外科杂志(电子版), 2021, 14(04): 237-238.
[8] 朱可安, 陈灵, 李昭, 黄薇. 应用单孔腹腔镜开展常见妇科手术的可行性探讨[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 158-162.
[9] 金贝贝, 张玉泉, 李季, 高赛楠, 朱春玉, 丁晓颖, 杨晓清. 普通及机器人辅助经脐单孔腹腔镜在子宫肌瘤剔除术中的应用比较[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 163-167.
[10] 徐晓钢, 曾纪晓, 刘斐, 兰梦龙, 陶波圆, 林玉珍. 经脐单孔3D腹腔镜手术治疗小儿先天性胆总管囊肿[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 172-176.
[11] 莫安胜, 关汉斌, 冯志强, 王蕊蕊, 覃明慧. 剑突及肋弓下三切口胸腔镜手术技术及改进[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 187-192.
[12] 卢攀 刘心怡 李坚 陈龙 张伟. 经脐单孔腹腔镜左半肝切除术[J]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 0-.
[13] 周启阳, 何宋兵, 胡优, 陈昕, 周晓俊. 单孔加一机器人辅助腹腔镜右半结肠切除术(附视频)[J]. 中华结直肠疾病电子杂志, 2021, 10(04): 445-448.
[14] 李丹, 谢坤, 陈倩倩, 刘昌华. 继发性甲状旁腺功能亢进症术后复发的防治[J]. 中华肾病研究电子杂志, 2021, 10(03): 166-169.
[15] 任占良, 张泳, 任小朋, 贺太平, 任占丽. 自发性气胸伴叶外型肺隔离症外科治疗1例[J]. 中华胸部外科电子杂志, 2021, 08(03): 190-193.
阅读次数
全文


摘要